Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2003
10/22/2003EP1354604A1 Combinations for cardiovascular indications
10/22/2003EP1354603A1 Concomitant drugs
10/22/2003EP1354602A1 Medicinal compositions containing diuretic and insulin resistance-improving agent
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1353933A1 Method for purification of lactose
10/22/2003EP1353918A1 Morpholine derivatives as antagonists of orexin receptors
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2003EP1353896A2 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
10/22/2003EP1353727A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drugor a statin, for the treatment of sexual dysfunction
10/22/2003EP1353696A2 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
10/22/2003EP1353695A2 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
10/22/2003EP1353694A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/22/2003EP1353677A2 Method of treatment of type i diabetes with vitamin d compounds
10/22/2003EP1353675A2 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1353671A1 Neurotrophic tacrolimus analogs
10/22/2003EP1353663A1 Fenofibrate tablets
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1353569A2 Preparation for improved dietary utilisation
10/22/2003EP1180121B1 Long lasting insulinotropic peptides
10/22/2003EP1178966B1 Quinoline derivatives as inhibitors of mek enzymes
10/22/2003EP1150961B1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
10/22/2003EP1140803B1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
10/22/2003EP1056701B1 E-2- 4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof
10/22/2003EP1041984B1 Pharmaceutical composition for oral administration
10/22/2003EP0881218B1 Preventives/remedies for complications of diabetes
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1451017A Selective cyclic peptides
10/22/2003CN1451006A I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450998A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450997A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450914A Preparation of aqueous clear solution dosage forms with bile acids
10/22/2003CN1450904A Use of ribose to prevent cramping and soreness in muscles
10/22/2003CN1450902A Medicinal composition composed of metformin and glyburide
10/22/2003CN1450077A Method for extracting polygonum cuspidatum tannic acid
10/22/2003CN1449816A Pharmaceutics for regulating blood-lipid and protecting liver and preparation process thereof
10/22/2003CN1449807A Yinxingle capsule and XinnaoXuekang capsule
10/22/2003CN1449783A Traditional Chinese medicine formule for treating hyperlipemia
10/22/2003CN1449768A Nano Selenium-calcium compound and preparation process thereof
10/22/2003CN1449762A Application of scutellarin composition in preparing medicine for preventing and treating diabetes complication
10/22/2003CN1449746A Soft capsule containing trace element
10/22/2003CN1449691A Anti-heatstroke effervescent beverage
10/22/2003CN1125081C Recombined natural and new-type human insulin and its preparation
10/22/2003CN1125079C Cyclopeptolides
10/22/2003CN1125070C Pyrrolo [2,3-d] pyrmidine compounds, and compositions and use thereof
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1124851C Chinese patent medicine for treating diabetes and nephrosis and its preparing process
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635762 Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
10/21/2003US6635680 Controlled release pellet formulation
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635638 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/21/2003US6635619 Amino acid sequence 88, 96, 97, 98, 99 or 100; increasing serum and tissue levels of active component
10/21/2003US6635451 Conversion of dihomo-gamma linolenic acid (DGLA) to arachidonic acid and in the conversion of 20:4n-3 to eicosapentaenoic acid (EPA); Delta 6 desaturase and Delta 5 desaturase
10/21/2003US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide
10/21/2003US6635270 NMDA receptor agonist pharmaceutical compositions
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/21/2003CA2237401C Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides
10/21/2003CA2208714C Bone mass anabolic composition comprising olpadronate
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/21/2003CA2141964C Pharmaceutical agents containing diphosphonic acids and salts thereof
10/21/2003CA2138161C Glucagon-like peptide and insulinotropin derivatives
10/16/2003WO2003085137A1 Antisense modulation of liver glycogen phosphorylase expression
10/16/2003WO2003085110A2 Oligomeric compounds for the modulation hif-1alpha expression
10/16/2003WO2003084966A1 Oxazolidinone derivatives
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084952A1 Benzoxazinone-derived compounds, their preparation und use as medicaments
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084939A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084930A1 Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
10/16/2003WO2003084923A1 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003WO2003084922A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084566A2 Proteins involved in the regulation of energy homeostasis
10/16/2003WO2003084564A1 Insulin administration apparatus
10/16/2003WO2003084549A1 Hormone replacement therapy
10/16/2003WO2003084535A1 Antidiabetic agents
10/16/2003WO2003084534A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
1 ... 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 ... 1298